Iryna Chastain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Iryna Chastain has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Kumar Mishra
Department of Cardiology, Concord Hospital, Concord, NH 03301, USA
1 shared publication - Kamal Kant Sahu
Department of Internal Medicine, Huntsman Cancer Institute, University of Utah
1 shared publication - Kevin Martin
Reliant Medical Group, Worcester, MA, United States
1 shared publication
Latest Publications
- Open Access
- 27 April 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (2) , 394-396
COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance
Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.
- 27 April 2020
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 90 (2) , 394-396
Open AccessCOVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance
Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.